These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6216344

  • 1. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
    Swarifi R, Lee M, Ojeda L, Tabib M.
    J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficacy of piperacillin versus carbenicillin for complicated urinary tract infections.
    Sharifi R, Lee M, Ojeda L.
    Urol Int; 1984 Oct; 39(6):345-51. PubMed ID: 6395464
    [Abstract] [Full Text] [Related]

  • 3. Comparison of mezlocillin and carbenicillin as therapy for various infectious diseases.
    Rolandi E, Barreca T, Ragni N, Valente U, Sannia A, Fontana I, Magnani G, Salvini P.
    Clin Ther; 1981 Oct; 4(4):321-5. PubMed ID: 6460558
    [Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of piperacillin therapy for infection.
    Pancoast S, Prince AS, Francke EL, Neu HC.
    Arch Intern Med; 1981 Oct; 141(11):1447-50. PubMed ID: 6456708
    [Abstract] [Full Text] [Related]

  • 5. Piperacillin v Carbenicillin in the therapy for serious infections.
    Marier RL, Sanders CV, Faro S, Janney A, Williams WW, Derks F, Aldridge KE.
    Arch Intern Med; 1982 Oct 25; 142(11):2000-5. PubMed ID: 6215008
    [Abstract] [Full Text] [Related]

  • 6. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.
    Simon GL, Snydman DR, Tally FP, Gorbach SL.
    Antimicrob Agents Chemother; 1980 Jul 25; 18(1):167-70. PubMed ID: 6448020
    [Abstract] [Full Text] [Related]

  • 7. Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
    Jones RN, Packer RR, Barry AL, Badal RE, Thornsberry C, Baker C.
    J Antibiot (Tokyo); 1979 Jan 25; 32(1):29-35. PubMed ID: 761991
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
    Monif GR, Clark PR, Shuster JJ, Baer H.
    Antimicrob Agents Chemother; 1978 Nov 25; 14(5):643-9. PubMed ID: 103491
    [Abstract] [Full Text] [Related]

  • 9. Clinical comparison of piperacillin and cefamandole in treatment of complicated urinary tract infections.
    Resnick MI, Kursh ED.
    Urology; 1987 May 25; 29(5):570-4. PubMed ID: 3554702
    [Abstract] [Full Text] [Related]

  • 10. Piperacillin susceptibility tests by the single-disk agar diffusion technique.
    Barry AL, Thornsberry C, Badal RE, Baker CN, Jones RN, Gerlach EH.
    Antimicrob Agents Chemother; 1979 Sep 25; 16(3):378-85. PubMed ID: 507794
    [Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of the therapeutic efficacy and tolerability of piperacillin.
    Lutz B, Mogabgab W, Holmes B, Pollock B, Beville R.
    Antimicrob Agents Chemother; 1982 Jul 25; 22(1):10-4. PubMed ID: 6214992
    [Abstract] [Full Text] [Related]

  • 12. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE.
    J Antimicrob Chemother; 1986 May 25; 17 Suppl C():93-6. PubMed ID: 3636340
    [Abstract] [Full Text] [Related]

  • 13. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
    Kohler RB, Foerster LA, Wheat LJ, Williams JM, Reynolds J, Norton J.
    Arch Intern Med; 1982 Jul 25; 142(7):1335-7. PubMed ID: 6212035
    [Abstract] [Full Text] [Related]

  • 14. Ofloxacin in the management of complicated urinary tract infections, including prostatitis.
    Cox CE.
    Am J Med; 1989 Dec 29; 87(6C):61S-68S. PubMed ID: 2690622
    [Abstract] [Full Text] [Related]

  • 15. Mezlocillin in the therapy of serious infections.
    Pancoast SJ, Jahre JA, Neu HC.
    Am J Med; 1979 Nov 29; 67(5):747-52. PubMed ID: 507086
    [Abstract] [Full Text] [Related]

  • 16. In vitro studies of piperacilin, a new semisynthetic penicillin.
    Winston DJ, Wang D, Young LS, Martin WJ, Hewitt WL.
    Antimicrob Agents Chemother; 1978 Jun 29; 13(6):944-50. PubMed ID: 677861
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with indanyl carbenicillin in urinary tract infections.
    Giamarellou E, Papazachos G, Piperakis G, Daikos G.
    Curr Med Res Opin; 1976 Jun 29; 4(2):170-6. PubMed ID: 776540
    [Abstract] [Full Text] [Related]

  • 18. [In vitro action and clinical use of indanyl carbenicillin].
    Fontana G, Laudi M, Sesia G, Savoia D, Cauda F.
    Minerva Urol; 1976 Jun 29; 28(6):285-8. PubMed ID: 827680
    [No Abstract] [Full Text] [Related]

  • 19. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM, Moellering RC.
    Ann Intern Med; 1982 Nov 29; 97(5):755-60. PubMed ID: 6215872
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N, Bremmelgaard A, Schouenborg P.
    Scand J Infect Dis Suppl; 1981 Nov 29; 29():27-30. PubMed ID: 6458882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.